EPN Forum 2012! Register Now!
The next EPN Forum will take place from 21st to 23rd March 2012, in Addis Ababa, Ethiopia. The biennial EPN Forum and General meeting (23rd March) are an opportunity for EPN members to meet physically to discuss and make critical decisions in relation to the activities of the Network. Click here to download the registration form for your participation in the Forum.
In 2010, during the EPN Forum in Nairobi, participants from 20 countries discussed strategies for building sustainable pharmaceutical systems and for the delivery of quality pharmaceutical services within the church sector. They came away with a sense that the two day forum provided them with an immeasurable learning experience and access to information and resources that would help them do their jobs more efficiently and effectively.

The next EPN Forum will take place from 21st to 23rd March 2012, in Addis Ababa, Ethiopia, at Desalegn hotel (http://www.desalegnhotel.com/). The theme of discussions will be ‘Access to quality medicines: priority needs, priority actions for today and tomorrow’. Note: the General Meeting on 23rd March is for EPN members only.
All EPN members, partners and stakeholders are invited. Participation fee is 200USD for EPN members (including accommodation and conference package) and 150 USD for non-members (covering only conference package). EPN will not be able to support participant’s transport or visa costs.
Click here to download the registration form for your participation in the Forum.
Confirmed speakers Christophe Luyckx Institute of Tropical Medicine, Coordinator QUAMED "Quality Medicines for All"
Topic: "Analysing, understanding and addressing the problem of poor quality medicines in low income markets" Bio: After 8 years experience in the field of pharmaceutical marketing and communication, Christophe Luyckx joined the humanitarian sector where he implemented social marketing programs for various NGOs, donors and consultancy offices, aimed at strengthening the impact of central medical stores for generic medicines in developing countries. Christophe has also served as CEO of PSF (Pharmaciens sans Frontières) and PAH (Pharmacie et Aide Humanitaire) and was Marketing Director of an important procurement agency for generic medicines where he developed the procurement channels from China and India. These various assignments and experience in over 20 countries led Christophe to identify the quality of medicines as a major concern for developing countries and encouraged him to join the Institute of Tropical Medicine of Antwerp where he currently coordinates QUAMED « quality of medicine for all ». Christophe holds a master’s degree in Social Communications and a University degree in Public Health and Health Promotion. Francis Aboagye-Nyame Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program (USAID)
Topic: 'Global programmes and access to medicines' Bio: Francis Aboagye-Nyame is the Program Director for the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program and the Strengthening Pharmaceutical Systems Program, a USAID-funded program implemented by Management Sciences for Health (MSH) and based in Arlington, Virginia. As Program Director, he is responsible for leading and managing the US Agency for International Development (USAID) funded, five-year $197.9 million Cooperative Agreement, Systems for Imp...roved Access to Pharmaceuticals and Services (SIAPS) Program, which is a follow-on to the Strengthening Pharmaceutical Systems (SPS) Program. The SIAPS Program builds on SPS’ achievements and works to assure the availability of quality pharmaceutical products and effective pharmaceutical services to achieve desired health outcomes. The program promotes and uses a systems-strengthening approach consistent with the Global Health Initiative (GHI) that will result in improved and sustainable health impact. The SIAPS’ technical approach emphasizes GHI principles, especially improving metrics, monitoring, and evaluation; capacitating local governments and organizations; and increasing country ownership. The SIAPS program works in about 30 countries with country offices in about 22. Mr. Aboagye-Nyame has over 20 years experience in pharmaceutical and supply chain management in developing countries and has worked on pharmaceutical sector assessments within both the public and faith-based health care sectors. Previously, he worked as Country Program Manager for the Supply Chain Management Systems (SCMS) Project in Botswana, Ethiopia, Namibia, and Tanzania. He was involved in the establishment of the Regional Pharmaceutical Forum of the East, Central, and Southern Africa (ECSA) region and in the development of the Coordinated Informed Buying Program, a regional collaboration for procurement initiatives in the ECSA region. Mr. Aboagye-Nyame was also involved in the assessment and design of MSH’s Strategies for Enhancing Access to Medicines (SEAM) Program in Ghana. Before coming to MSH, he was the head of the Procurement Unit at the Ghana Ministry of Health (MOH), with responsibilities for procuring goods, works, and services and for establishing and institutionalizing procurement policies, procedures, and systems in the Ministry; he also served as a pharmacist and Deputy Program Manager of the Ghana National Drugs Program at the Ministry. Mr. Aboagye-Nyame has experience in formulating policy; implementing and monitoring programs and activities aimed at promoting rational drug use; strengthening quality assurance of pharmaceuticals and pharmaceutical systems; improving the financing of drugs; and supply chain management. He also has extensive experience in the design and provision of training in pharmaceutical and supply chain management at the national and international levels. A pharmacist, Mr. Aboagye-Nyame holds a Masters in Business Administration with an emphasis in Finance from the University of Ghana and a Master of Science in Pharmaceutical Analysis and Quality Control from the University of London. He is a member of the Pharmaceutical Society of Ghana and a Fellow of the West African Post Graduate College of Pharmacists. Matthew O. Azoji CHAN Medi-Pharm Ltd/.Gte, CEO
Bio: Matthew O. AZOJI, Managing Director/CEO of CHAN Medi-Pharm Ltd/Gte, is a pharmacist with about 25 years experience in sales, marketing, business development, procurement & supply management and strategic/general management in the pharmaceutical and public health sectors of Nigeria. Mr. Azoji has a First Class degree in Pharmacy, an MBA, Advanced Management Programme (AMP) and a Postgraduate Diploma (PG Dip) in Public Health from different universities in Nigeria and the United Kingdom. As Managing Director/CEO of CHAN Medi-Pharm Ltd/Gte, Jos Nigeria, a Director of Essential Pharma Ltd, Makurdi, Nigeria and Board member of Ecumenical Pharmaceutical Network (EPN), Mr. Azoji is currently involved in strengthening systems to enhance access to essential medicines in Nigeria and environs. Dr William Mwatu Gllaxo Smith Kline (GSK), Medical and Regulatory Affairs Director East Africa

Topic: 'Enhancing the pipeline of new medicines for low income markets'
Bio: Dr Mwatu, Medical and Regulatory Affairs Director East Africa at GSK has numerous years of experience in the pharma industry. In addition to his many years with GSK, he has worked with Procter and Gamble East Africa and the Ministry of Health in Kenya. Dr Mwato holds an MBA of Newport University and bachelor in Pharmacy from University of Nairobi. He is a member of the steering committee of the African Medicines Harmonization initiative, a member of the National Bioethics committee of Kenya, a member of the Pharmaceutical Association of Kenya and of the Association of Clinical Trial Professionals. He is also the Chair of the Steering committee of the East African Federation of Pharmaceutical Manufacturers and the vice-chair of the Kenya Association of Pharmaceutical Industry. More information on the programme will follow soon.
Read more: |